MDCX SCHEDULE 13D: Activist campaign
Dr. Raza Bokhari and RBx Capital, LP
Filed with the SEC on · accession 0000950142-26-002546
MDCX filed a SCHEDULE 13D (schedule 13d) with the SEC on Sep 14, 2026. Dr. Raza Bokhari and RBx Capital, LP filed a joint Schedule 13D regarding their position in Medicus Pharma Ltd., indicating a potentially active ownership stake. The stock moved -2.0% by the first close after the filing.
Summary of the filing
Dr. Raza Bokhari and RBx Capital, LP filed a joint Schedule 13D regarding their position in Medicus Pharma Ltd., indicating a potentially active ownership stake. The filing itself is a joint filing agreement and does not disclose the size or purpose of the position.
Key details
How MDCX stock reacted
Close before
$8.13
Sep 11, 2026
First close after
-2.03%
$7.96
5 trading days
+4.74%
$8.52
Since filing
-77.49%
$1.83
✦ Ask GOAX AI about this filing — what it means for MDCX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for MDCX?
Click hereFrequently asked questions
What did MDCX file with the SEC on Sep 14, 2026?
MDCX filed a SCHEDULE 13D (Activist campaign). Dr. Raza Bokhari and RBx Capital, LP filed a joint Schedule 13D regarding their position in Medicus Pharma Ltd., indicating a potentially active ownership stake. The filing itself is a joint filing agreement and does not disclose the size or purpose of the position.
What does a activist campaign mean for MDCX stock?
A settlement removes uncertainty; the stock often reacts to whether the amount is bigger or smaller than investors expected.
How do I read a SCHEDULE 13D?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D (schedule 13d): A report the company filed with the SEC (the US market regulator).
How did MDCX stock react to this filing?
MDCX closed at $8.13 before the filing and $7.96 on Sep 14, 2026 (-2.03%). Five trading days later: $8.52 (+4.74%).
Other MDCX SEC filings
Get alerts when MDCX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days